Metabolic health platform Virta Health has secured $133.0M in Series e funding, continuing its mission to reverse chronic conditions without surgery or deprivation. The Denver-based company aims to address the root cause of metabolic disease in one billion people, helping members reduce or eliminate medications through AI-powered, personalized nutrition therapy and human care.
Virta partners with some of the nation’s largest employers, payers, and pharmacy benefit managers, working to improve the health of their members while simultaneously reducing costs. This latest capital injection will support its efforts to transform how metabolic health care is delivered at scale.
